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Interleukin-1β is a potent proinflammatory cytokine, of which processing and secretion are
tightly regulated. After exposure to various stimuli, mononuclear phagocytes synthesize
the inactive precursor (pro-IL-1β), which is then cleaved intracellularly by caspase-1 and
secreted. A widely used method for in vitro secretion of IL-1β employs LPS-primed human
peripheral blood monocytes. Subsequently, adenosine triphosphate (ATP) is added to the
cells in order to trigger the P2X7 receptor resulting in processing and secretion of mature
IL-1β. However, it is often reported that secretion is due to cytotoxic effects of ATP with
P2X7 receptor-activation-related cell death. We have challenged this concept and demon-
strate IL-1β specific secretion, since there is no increase in cell death and IL-1α and IL-18
are not released in the same cultures. More importantly we show that these conclusions
can only be drawn under stringent experimental conditions.
Keywords: interleukin-1, ATP, active secretion, cell death, stringent experimental conditions
INTRODUCTION
IL-1β is a potent cytokine able to induce inflammation. It has a
role in infection, diabetes, heart failure, and neuro-inflammatory
diseases (1, 2) as well as several autoinflammatory diseases.
It is a product of monocytes/macrophages, dendritic cells, nat-
ural killer-cells, and B-lymphocytes (1). When stimulated with
pathogen associated molecular patterns, such as LPS, or damage
associated molecular patterns, these cells produce inactive pro-IL-
1β with a molecular weight of 31 kDa (1, 3), which accumulates
in the cytosol. As mature IL-1β lacks a signal peptide, its secre-
tion was enigmatic until crucial experiments done by Rubartelli
shedded light (4); when a second signal, such as extracellular
adenosine triphosphate (ATP), activates the cation-selective P2X7
receptor on the cell membrane, a potassium efflux occurs, via a
pore permeable to hydrophilic solutes up to 900 Da (5–7). This
fall of intracellular potassium triggers assembly of the inflam-
masome protein complex, which in turn leads to production of
active caspase-1. Activated caspase-1 cleaves the precursor of IL-1β
into an active 17 kD form, which is secreted (1, 8). Several reports
showed that specific polymorphisms in P2X7 impair its function
(9–12) and as a result, IL-1β secretion is reduced, suggesting a vital
role for P2X7 in IL-1β secretion (13).
In a pioneering study, Ferrari et al. (8) described a model
now widely used to study IL-1β release, which consists of brief
LPS-stimulation for induction of pro-IL-1β (called “priming”),
followed by ATP stimulation of PBMCs to enhance secretion
(8, 14–16). Even with purified LPS-stimulation alone, ATP from
endogenous source is thought to be involved (17). Since IL-1β
lacks a signal sequence for compartmentation within the Golgi and
release through classical secretory vesicles, non-classical mecha-
nisms are required for its secretion, which were recently reviewed
by Dubyak (18). These include the secretory lysosome (containing
accumulated IL-1β) pathway, the release of membrane-delimited
microvesicles (surface membrane evaginations that entrapped
cytosolic IL-1β) [Ref. (19, 20) and reviewed in detail in Ref. (21)],
the release of membrane-delimited exosomes that occurs after the
formation of multivesicular bodies by recycling endosomes that
have entrapped IL-1β (22), and exocytosis of autophagosomes or
autophagolysosomes.
Alternatively, it has been suggested that activation of the P2X7
receptor leads to cell death and that IL-1β is passively released with
loss of membrane integrity rather than actively secreted (15, 23,
24). In the present report we investigated this issue.
MATERIALS AND METHODS
IN VITRO CYTOKINE PRODUCTION
PBMCs obtained from venous blood or buffy coats from healthy
volunteers were isolated using Ficoll gradient separation. This
research was approved by the local ethics committee and volun-
teers gave written informed consent.
Media and ATP solutions
RPMI 1640 medium (Invitrogen, Paisley, UK) supplemented
with 1 mM sodium pyruvate (Sigma-Aldrich), 2 mM l-Glutamine
(Merck) and 50µg/ml gentamicin was used. No serum was added.
For preparing ATP solutions, the following directions were care-
fully followed. First, the amount of ATP (Sigma,A6419) needed for
the experiment was weighed in an Eppendorf tube. Calculations
and solutions (excluding ATP) were all prepared beforehand. At
the desired time of preparation (fresh, or x minutes before adding
to the plates), the ATP in the Eppendorf tube was dissolved in
medium to generate a 100 mM stock and was immediately further
diluted into the pre-pipetted tubes yielding the final ATP con-
centrations. ATP solutions were immediately added to the cells.
This had to be done as fast as possible to make sure that the time
between preparation of the ATP solution and adding this to the
cells was 2 min (or as otherwise indicated in the figures). Usage
of automated multi-channel pipets is highly recommended. All
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solutions were prepared from medium pre-warmed at 37°C and
kept in the laminar flow cabinet, with an inside temperature of
21°C, until adding them to the cells.
Experimental procedure
Hundred microliter of cells at a concentration of 5.0× 106/ml was
pipetted into 96-wells U-bottom plates (Greiner 650180) and cells
were exposed to LPS for 24 or 3 h [Sigma, Escherichia coli 055:B5,
purified as described (25)] in a total volume of 200µl. For the 3 h
incubation in combination with ATP we added 100µl of medium
or medium containing 2µg/ml LPS to 100µl of cells, resulting in
a final LPS concentration of 1µg/ml for a total of 500,000 cells
in each well. Samples were prepared in duplicates. After 3 h of
incubation at 37°C, the medium was removed from the cells by
careful pipetting. Then 200µl of medium, or ATP in medium was
added and incubated for exactly 15 min at 37°C, after which cells
were spun down at 350 g for 8 min at room temperature. One
hundred fifty microliter supernatant per well was collected and
pooled with its duplicate, such that in total 300µl supernatant
per condition was collected. The remaining 50µl supernatant was
discarded because this may have contained cell material. Hundred
microliter of medium (same as used for the incubation) was added
to the remaining cells, and plates were subjected to three cycles of
freeze-thawing. Plates were spinned as described above and 80µl
supernatant was collected and pooled with its duplicate for cell-
associated cytokine analysis. To obtain experimental replicates,
we repeated the experiments with different donors and at vari-
ous days. Cytokine concentrations were measured using ELISA
(R&D systems; IL-1α, total IL-1β, and specific intact pro-IL-1β) or
Luminex (Bio-Rad; IL-18). Detection limits for IL-1β, IL-1α, and
pro-IL-1β ELISAs were 39, 39, and 70 pg/mL, respectively.
CELL VIABILITY ASSAYS
Cell viability was assessed by two independent LDH assays; in
supernatants measured by ARCHITECT C16000 system (Abbott
Laboratories, USA), and measured in phenol-red free supernatants
by CytoTox96 Non-Radioactive cytotoxicity assay according to
manufacturer’s instructions (Promega, Madison, USA). In the
latter, stimulated samples were compared to the non-stimulated
samples (viable controls); lysed cells from the same donors served
as positive controls. In addition, we employed trypan blue staining
(Sigma, St. Louis, USA) and an AnnexinV-PI staining according to
the manufacturer’s recommendations (Biovision, Milpitas, USA).
In brief, after the indicated stimulations, cells were resuspended in
AnnexinV-FITC Staining solution and incubated in the dark for
15 min on ice. PI was added and cells were incubated in the dark
for another 5 min on ice. The cells were measured on a FC500 flow
cytometer (Beckman Coulter) and the data were analyzed using
CXP analysis software v2.2 (Beckman Coulter).
qRT-PCR
Total RNA was extracted from PBMCs using TRIzol reagent
(Invitrogen), subjected to DNAse treatment (Ambion® DNA-
free™ Kit, Invitrogen) and reverse-transcribed into cDNA
(iScript cDNA Synthesis Kit, Bio-Rad). qRT-PCR was performed
using an Applied Biosystems 7300 real-time PCR using the
following primers: IL-1β: 5′-CAGCTACGAATCTCCGACCAC-
3′ (forward) and 5′-GGCAGGGAACCAGCATCTTC-3′ (reverse);
β2M: 5′-ATGAGTATGCCTGCCGTGTG-3′ (forward); and 5′-
CCAAATGCGGCATCTTCAAAC-3′ (reverse).
STATISTICAL ANALYSIS
Results were analyzed using the Wilcoxon matched-pairs signed
rank test for non-normally distributed paired data, in GraphPad
Prism, version 5.00 (GraphPad Software, San Diego, CA, USA).
***p≤ 0.001; **p≤ 0.01; *p≤ 0.05.
RESULTS
In human PBMCs priming with LPS alone for 3 h led to IL-
1β secretion (mean 0.25 ng/mL± 0.07 SEM, n= 12), which was
significantly elevated when followed by ATP exposure (mean
1.53 ng/mL± 0.46 SEM, p< 0.001, n= 12) (Figure 1A). Secre-
tion of another IL-1 family member cleaved by caspase-1, IL-18,
was not increased (IL-18 concentration in supernatant in all sam-
ples below level of detection). Upon LPS-priming, IL-1β mRNA
expression increased 21-fold. However, ATP stimulation did not
further influence the IL-1β mRNA expression (Figure 1B). Prim-
ing also induced the expression of intracellular pro-IL-1β protein
(Figure 1C). The additional pulse with ATP had no effect on these
concentrations. There was an increase in intracellular total IL-1β
concentration after ATP (Figure 1A).
We assessed cell viability by trypan blue staining and LDH
release. In our experiments, neither of the stimuli increased cell
death, compared to unstimulated samples (data not shown).
In addition, though LPS-priming induced production of IL-
1α this was not secreted into the supernatant, not even in the
presence of ATP (Figure 1D). After 24 h of stimulation with
either 1 or 10 ng/mL LPS however, cells were secreting IL-1α,
in a dose-dependent manner (means 132 pg/mL± 22 SEM, and
282 pg/mL± 55 SEM, respectively, n= 16) (Figure 1E). This was
not due to cell death, as LDH remained below the detection limit
(data not shown).
The ATP stimulus is crucial for actual secretion of IL-1β in vitro.
Therefore, we tested the influence of the quality of the ATP solu-
tions. Dissolving ATP in RPMI 2 min before addition to the cells
resulted in a significant increased IL-1β secretion. If ATP was dis-
solved 20 min before addition, the effect was completely abrogated
(Figure 1F).
Next, we studied whether the ATP concentration could over-
come the diminished stimulatory capacity of the “older” ATP
preparation. As shown (Figure 2), cells stimulated with LPS and
subsequently with ATP that was prepared 2 min (Figure 2A),
10 min (Figure 2B), or 20 min (Figure 2C) before addition, all
secrete IL-1β. However, IL-1β secretion decreased with increasing
time in between the preparation and the stimulation with ATP.
Also, at each time point 3 mM ATP induces a greater IL-1β secre-
tion than 1 mM ATP. However, the 5 and 10 mM concentrations
do not increase the response further. Thus, the maximum response
in this cell model is observed at 3 mM ATP. Nevertheless, even this
response is not able to overcome the preparation effect; with a
20 min 3 mM ATP preparation IL-1β secretion is still lower than
with a 2 min 1 mM ATP preparation.
To investigate the effects of the different ATP concentrations
on cell viability we further used AnnexinV-PI staining. At the
early stages of apoptosis, cells start exposing phosphatidylserine
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FIGURE 1 | IL-1 concentrations. PBMCs were incubated with either medium
or 1µg/ml LPS for 3 h, and additionally with medium or 1 mM ATP for 15 min.
All cytokines were measured in the same preparations (n=12). (A) Significant
increased IL-1β levels after stimulating LPS-primed PBMCs with 1 mM ATP
compared to LPS-priming only. (B) LPS-induced IL-1β mRNA expression.
(C) Intracellular pro-IL-1β levels. (D) LPS-induced intracellular IL-1α
concentrations. No IL-1α could be detected in supernatants. (E) PBMCs
incubated for 24 h with 1 or 10 ng/mL LPS (n=16) secrete significantly more
IL-1α than unstimulated PBMCs, in a dose-dependent manner.
(F) Comparison of IL-1β secretion after adding ATP 2 or 20 min after
preparation (n=6). IL-1β levels were determined in a separate experiment,
using the same setup. All data are represented as mean+SEM. IL-1β levels
detected in (A,F) represent both mature and pro-IL-1β, whereas in
(C) specifically intact pro-IL-1β levels were detected.
FIGURE 2 | Effect of ATP preparations on IL-1β secretion. PBMCs
were incubated with either medium or 1µg/ml LPS for 3 h, and
additionally with medium or different concentrations of ATP for 15 min.
We observed a dose dependent increase in IL-1β secretion regardless of
the time in between the ATP preparation and the stimulation, with a
maximum response at a dose of 3 mM ATP. IL-1β secretion was higher
when fresh ATP preparations were used (A), as compared to older
preparations, e.g., 10 min (B), and 20 min old (C). Results from two
independent experiments with a total of six donors were pooled and
represented as mean+SEM.
(PS) to the external cellular environment, making them positive
for AnnexinV-FITC staining. Loss of membrane integrity in late
apoptotic or necrotic cells renders them permeable to PI. After 3 h
LPS followed by 15 min ATP stimulation, only higher ATP concen-
trations (≥3 mM) induce cells to become late apoptotic or necrotic
(AnnexinV+/PI+), although only at a low percentage (Figure 3A).
www.frontiersin.org February 2015 | Volume 6 | Article 54 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stoffels et al. ATP-induced IL-1β specific secretion
FIGURE 3 |The effect of fresh ATP preparations on cell membrane
integrity. (A) Cells that lost membrane integrity stain positive for AnnexinV
and PI, and can be late apoptotic or necrotic. (B) Cells that stain only
positive for AnnexinV are early apoptotic but have not lost membrane
integrity. Higher concentrations of ATP cause more cell death (A) than a
low concentration. ATP induces early apoptosis in all concentrations
(B). Results from two independent experiments with a total of six donors
were pooled and represented as mean+SEM.
Early apoptotic cells (AnnexinV+/PI−) were observed at all ATP
concentrations (Figure 3B). In the absence of LPS cells were more
sensitive to the ATP stimulus, than in the presence of LPS, as
indicated by the black bars and white bars, respectively (Figure 3).
DISCUSSION
We confirmed earlier findings (8, 15, 16) that PBMCs from human
volunteers secrete significantly more IL-1β when primed with LPS
for 3 h followed by a pulse with ATP for 15 min compared to
LPS-stimulation alone (Figure 1A). This difference is not due to
increased mRNA expression (Figure 1B) or an increase in the
intracellular level of pro-IL-1β (Figure 1C). This confirms that
ATP-induced P2X7 activation leads to caspase-1 activation, and
the processing of pro-IL-1β and secretion of the mature molecule.
It is interesting to note that the total levels of IL-1β are higher,
while intracellular pro-IL-1β levels remain similar when compar-
ing the LPS and LPS+ATP stimulation. This may be explained by
a simultaneous increase in translation efficiency and cleavage of
pro-IL-1β under influence of ATP. In addition, Levandowski et al.
reported that a SNP in NLRP1 results in increased IL-1β secretion,
while pro-IL-1β levels remained similar (26). Alternatively, on the
total levels of IL-1β, the percentage of secreted IL-1β is very low
compared to the percentage of pro-IL-1β present in the cells, and it
is therefore possible that a significant decrease in pro-IL-1β would
not be observed.
There are a number of controversies or uncertainties regard-
ing the effects of ATP in this setting. First, whether the effect is
due to cell death or not. Ferrari et al. observed no increase in
cell death after exposure of LPS-primed macrophages to ATP (8),
while Brough et al. did report ATP increased cell death (15) as evi-
denced by increased IL-1α and LDH (15, 27). In our experiments,
15 min incubation of 1 mM of ATP to LPS-primed PBMCs did not
increase cell death as detected by LDH and AnnexinV-PI staining.
Despite high intracellular concentrations of IL-1α after 3 h of LPS-
stimulation (either with or without ATP pulse), we detected no
increase in the supernatants (Figure 1D). This confirms that the
cell membrane is intact, and it follows therefore that extracellular
IL-1β concentrations are due to active secretion rather than pas-
sive release. Differences in experimental conditions in the studies
mentioned (5 vs. 1 mM ATP; 30 vs. 15 min ATP incubation) (8,
15) could very well explain these discrepancies.
Secondly, is this ATP effect specific for IL-1β or does ATP facili-
tate the release of other cytokines from the same cell? For example,
Fettelschoss et al. (28) reported that ATP is needed for secretion of
IL-1α after 24 h of stimulation with LPS. We found no effect of ATP
on the LPS-induced increase in intracellular IL-1α concentration
(Figure 1D); and after 24 h of incubation LPS alone was suffi-
cient to induce secretion of IL-1α (Figure 1E). This was not due
to increased cell death as determined by LDH measurement (not
shown). These data also do not support the hypothesis that secre-
tion of IL-1α is coupled to secretion of IL-1β (Figures 1A,D,E)
(28). We found no increased secretion of IL-18, another cytokine
of the IL-1 family that is processed by caspase-1 (data not shown).
Although both IL-1β and IL-18 are substrates for caspase-1, they
are regulated differently (29), and since IL-1β in this assay is
detected before the peak in its secretion, this may also explain why
IL-18 secretion remained below our detection limit. Accordingly,
the effect of ATP stimulation is specific for IL-1β.
A final controversy is that the result of the LPS/ATP model is
not always consistent. For example, Ferrari et al. found that LPS-
primed monocytes did not exhibit an increase in IL-1β secretion
after stimulation with ATP, although macrophages did (8). Our
data do show an increase in IL-1β secretion in PBMCs (largely orig-
inating from monocytes). Other studies routinely use much higher
ATP concentrations (15). A crucial factor is likely to be the prepa-
ration of the ATP. As we demonstrate here, for optimal results ATP
needs to be dissolved within 2 min before addition; when we pre-
pared ATP 20 min before adding it to the cell preparations, there
was no significant effect on secretion (Figure 1F). The difference
of merely 18 min in preparation time completely abrogates the
effect. This could be due to phosphohydrolysis of ATP, which may
explain why some laboratories need to add a higher (almost toxic)
total concentration of ATP to see any increased secretion of IL-1β.
This higher total ATP concentration may induce cell death. In our
model we have consistently used 1 mM ATP to stimulate the cells,
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although 3 mM is considered the optimal concentration. Our data
show that cells do secrete IL-1β in response to this sub-optimal
dose, which is closer to physiologically relevant levels. More impor-
tantly, at this dose, we could not observe cell death, whereas higher
ATP concentrations do cause cell death (Figure 3). This is sup-
ported by results in a study of Kuhny et al. (30), in which the use
of low or high dose ATP resulted in differences in ATP-induced
morphological changes in mast cells as measured by flow cytome-
try. Here, 0.3 mM ATP led to minor increase of the forward scatter,
while stimulation with 3 mM ATP induced the formation of a 2nd
PI positive population with increased side scatter and smaller cell
bodies. Moreover, in our experiments, even stimulation with high
concentrations of ATP could not overcome the effect of the 20 min
between preparation and stimulation (Figure 2). Thus, immediate
preparation of ATP right before addition is of vital importance.
In summary, we confirmed the validity of the LPS/ATP model.
IL-1β secretion is selective and not due to passive release by
a cytotoxic effect of ATP. Moreover, our results emphasize the
importance of stringent experimental conditions, i.e., using freshly
prepared ATP in this model.
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